You just read:

Oncolytics Biotech® Inc. Announces Positive Results of U.S. Phase 2 Clinical Trial Investigating REOLYSIN® in Combination with Paclitaxel and Carboplatin in Head and Neck Cancers

News provided by

Oncolytics Biotech Inc.

Nov 14, 2011, 07:00 EST